Heartflow, Inc. Common Stock (HTFL) Insider Trading

Over the last 3 months, HTFL insiders made 0 open-market buys and 10 sales, a net sale of -$64.0M (SEC Form 4). Over the last 6 months, 85 institutions increased and 40 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
10
Net (3m)
-$64.0M
Insider trades by month Buys Sells
Dec
Feb
Mar
Apr
May
Jun
Context3-month price +20.6%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Jun 26, 2026Farquhar John C.M.director, officer: Chief Executive OfficerSell38,900$35.00
Jun 18, 2026WELDON WILLIAM CdirectorGrant16,075$32.05
Jun 18, 2026Cullivan Julie AdirectorGrant16,075$32.05
Jun 18, 2026BARABE TIMOTHY CdirectorGrant16,075$32.05
Jun 18, 2026Tansey Casey MdirectorGrant16,075$32.05
Jun 18, 2026Riley Wayne JosephdirectorGrant16,075$32.05
Jun 18, 2026Lightcap Jeffrey CdirectorGrant16,075$32.05
Jun 17, 2026Rogers Campbellofficer: Chief Medical OfficerOption10,000$2.22
Jun 12, 2026Farquhar John C.M.director, officer: Chief Executive OfficerSell22,562$28.50
May 20, 2026Rogers Campbellofficer: Chief Medical OfficerOption9,219$19.00
May 20, 2026Rogers Campbellofficer: Chief Medical OfficerSell9,219$28.34
May 13, 2026Farquhar John C.M.director, officer: Chief Executive OfficerSell22,562$29.12
May 8, 2026Verghese Vikramofficer: Chief Financial OfficerTax473$29.98
May 8, 2026Farquhar John C.M.director, officer: Chief Executive OfficerTax1,904$29.98
May 8, 2026Farquhar John C.M.director, officer: Chief Executive OfficerTax5,300$30.29
May 8, 2026Verghese Vikramofficer: Chief Financial OfficerTax1,536$30.29
May 8, 2026Rogers Campbellofficer: Chief Medical OfficerTax637$29.98
May 8, 2026Rogers Campbellofficer: Chief Medical OfficerTax1,634$30.29
May 8, 2026Jones Marie L.officer: Chief Accounting OfficerTax82$29.98
May 8, 2026Jones Marie L.officer: Chief Accounting OfficerTax485$30.29
Apr 30, 2026Bain Capital Life Sciences Investors, LLC10 percent ownerSell56,224$30.05
Apr 30, 2026Bain Capital Life Sciences Investors, LLC10 percent ownerSell892,533$29.18
Apr 30, 2026Bain Capital Life Sciences Investors, LLC10 percent ownerSell797,133$29.37
Apr 30, 2026Bain Capital Life Sciences Investors, LLC10 percent ownerSell254,110$30.51
Apr 14, 2026Farquhar John C.M.director, officer: Chief Executive OfficerSell22,562$26.72
Apr 3, 2026Rogers Campbellofficer: Chief Medical OfficerOption40,766$2.22
Apr 3, 2026Rogers Campbellofficer: Chief Medical OfficerOption291$8.33
Apr 3, 2026Rogers Campbellofficer: Chief Medical OfficerSell64,533$24.64
Apr 3, 2026Rogers Campbellofficer: Chief Medical OfficerOption6,849$2.22
Apr 3, 2026Rogers Campbellofficer: Chief Medical OfficerOption19,111$2.22

Source: HTFL SEC Form 4 filings, latest Jun 26, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their HTFL positions over the last 6 months (SEC Form 13F).

Increased
85
New positions
126
Reduced
40
Sold out
40
Largest moves
InstitutionActionSharesFiled
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLCUnchanged12.4MFeb 17, 2026
WELLINGTON MANAGEMENT GROUP LLPIncreased12.0MMay 15, 2026
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLCReduced10.4MMay 15, 2026
WELLINGTON MANAGEMENT GROUP LLPIncreased5.9MFeb 17, 2026
FMR LLCIncreased5.4MMay 15, 2026
JANUS HENDERSON GROUP PLCIncreased4.4MMay 18, 2026
FMR LLCReduced4.1MFeb 17, 2026
BAMCO INC /NY/Increased3.8MMay 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position3.8MMay 15, 2026
BAILLIE GIFFORD & COUnchanged3.0MJan 23, 2026
BAMCO INC /NY/Increased2.3MFeb 17, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position2.0MMay 8, 2026
SCHUSTERMAN INTERESTS, LLCUnchanged1.9MFeb 17, 2026
INVESCO LTD.Increased1.9MMay 12, 2026
CAPRICORN INVESTMENT GROUP LLCNew Position1.7MFeb 17, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.